The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2009Enhanced Delivery of Viral Vectors to Striatum with Solid-State Biodegradable Matrices
Objective/Rationale:
When treating patients with neurological disorders, physicians frequently administer drugs through a small plastic tube or needle placed into the target area of the brain... -
Clinical Intervention Awards, 2009NIC-PD Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease
Objective/Rationale:
No drugs are available that can slow or stop the progression of Parkinson’s disease (PD). Nicotine is a promising substance for this purpose. Firstly, epidemiological studies... -
Understanding LRRK2 Biology, 2009Characterization of LRRK2 Cellular and Signaling Pathways
Objective/Rationale:
Mutations in LRRK2 are thus far the most common known cause of late-onset Parkinson’s disease (PD). The most prevalent LRRK2 mutation G2019S has been shown to stimulate LRRK2... -
Understanding LRRK2 Biology, 2009Elucidating the Function and Downstream Targets of LRRK2
Objective/Rationale:
One of the most exciting recent advances in PD research is that mutations within the gene coding for a protein of unknown function, LRRK2, predispose people to PD. Since a number... -
Understanding LRRK2 Biology, 2009LRRK2 in Neuronal Architecture
Objective/Rationale:
Past observations in LRRK2 pre-clinical models have lead us to develop a unified hypothesis for LRRK2’s role in signaling/scaffolding and neuronal membrane dynamics. By utilizing... -
Understanding LRRK2 Biology, 2009Investigating signaling pathway dysfunction linked to LRRK2
Objective/Rationale:
Mutations in the gene LRRK2 are responsible for tens of thousands of cases of Parkinson’s disease, and are the most common genetic cause of this disease. At present we don’t...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.